ENT Devices Market by Product - Global Industry Analysis and Forecast to 2025

Report Code : HC0655

Ear, nose, and throat (ENT) disorders are the most common reasons for visits to a primary care physician. Most patients with ENT disorders visit the doctor early in the disease process as associated symptoms and signs are readily visible. The physical appearance of the tongue, teeth, gums, and palate indicates different physiological states. These indications can be used to detect and diagnose the particular disorder. Some of the common ENT disorders are chronic, acute and recurrent tonsillitis, recurrent and acute otitis media (OM), and recurrent and allergic rhinitis along with chronic rhinosinusitis (CRS). Common cold is the most frequent upper respiratory tract infection (URI). Nearly half of the cases of cold affecting children can be attributed to a variety of up to 200 distinct viruses which are seasonally active (Source: Journal of Biomedical Therapy 2010 Vol. 4, No. 2). For instance, rhinoviruses are active in the early fall, summer, and spring. Disorders related to the ear such as hearing loss constitute a considerable share of ENT disorders. According to the National Institute of Deafness and Other Communication Disorders (NIDCD), 2 to 3 among every 1,000 children in the U.S. are born with detectable level of hearing impairment in one or both ears. Hearing aids and hearing implants are used to treat the hearing impaired patients. While hearing aids amplify the incoming sound, implants transform sound into electrical signals that stimulate the patient’s auditory nerve.

Some of the key factors driving the ENT devices market are rising incidence of ENT related infections and traumas, increased prevalence of geriatric population around the world, and growing awareness about ENT disorders and their prevention and cure among the target population. According to the data revealed by the (NIDCD) in 2016, the highest amounts of hearing loss disorders exist in the age group between 60 and 69. As per a study conducted by Action on Hearing Loss, in 2015, over 11 million people in UK were living with some form of hearing loss, which amounts to one in every 6 persons in the UK. According to the data revealed in 2016 by healthdirect, an information service supported by Government of Australia, adults usually encounter 2 to 4 colds every year whereas, children usually get affected by cold 5 to 10 times in a year as they are less immune to cold causing viruses. Such high prevalence of common cold in children and adults will favorably contribute to the growth of ENT devices market over the forecast period. However, factors such as high cost and unfavorable reimbursement policies for hearing aids are likely to hinder the growth of ENT devices market.

Technological advancements in ENT diagnostic and surgical devices will offer lucrative growth opportunities for the manufacturers. Latest developments in minimally invasive Trans-Oral Robotic Surgeries (TORS) are highly effective as recovery time for patients undergoing such surgeries is considerably reduced. In these surgeries, surgeons use computer enhanced, sophisticated systems to remove oral cancers assisted by an enhanced view of the existing cancer and the surrounding tissue.

Some of the key players in the ENT devices market are Medtronic plc., Stryker Corporation, Olympus Corporation, KARL STORZ GmbH & Co. KG, Smith & Nephew plc., Sonova Holdings AG, Acclarent, Inc., William Demant Holdings A/S, and Cochlear Limited. Development of technologically advanced ENT devices is the key strategy adopted by these players. For instance, in September 2016, Med-El obtained FDA approval for its SYNCHRONY EAS (Electrical Acoustic Stimulation) hearing implant system. This system is a combination of two technologies viz. the Synchrony cochlear implant technology, which is used to stimulate the auditory nerve in high frequency hearing loss, and the SONNET EAS audio processor, which has built-in acoustic amplification used for low frequency hearing loss.

ENT Devices Market Segmentation:

By Product:

  • Diagnostic ENT Devices
    • Flexible Endoscopes
    • Hearing Screen Devices
  • Rigid Endoscopes
      • Laryngoscopes
      • Otological Endoscopes
      • Rhinoscopes
    • Robot Assisted Endoscope
  • Hearing Aids ENT Devices
    • Behind-the-Ear Hearing Aids
    • In-The-Ear Hearing Aids
    • Canal Hearing Aids
    • Receiver-In-The-Ear Hearing Aids
  • Surgical ENT Devices
    • Radiofrequency Handpieces
    • Otological Drill Burrs
    • Powered Surgical Instrument
    • ENT Hand Instruments
    • Sinus Dilation Devices
    • Tympanostomy Tubes
    • Nasal Packing Devices
  • Nasal Splints ENT Devices
    • Internal Nasal Splints
    • External Nasal Splints

By Region:

  • North America
  • U.S
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • Australia
  • India
  • South Korea
  • Rest of Asia-Pacific
  • Rest of the World
  • Brazil
  • South Africa
  • Saudi Arabia
  • Turkey
  • United Arab Emirates
  • Others

Research Methodology

We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.

Data Mining

Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.

Data Collection Matrix

Data Collection Matrix

Supply Side

Demand Side

Primary Data Sources

  • Manufacturers
  • Distributors & Wholesalers
  • GPOs
  • Physicians/Specialist
  • Healthcare Providers
  • Consumers

Secondary Data Sources

  • Annual Reports/SEC Filings/ Investor Presentations/ Press Releases
  • Government/Associations Publications
  • Case Studies
  • Reference Customers


Market Modeling and Forecasting

We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.

  • Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
  • Number of patients for particular device or medical procedure and
  • Repeated use of particular device depending on health and condition of patient
  • Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.

We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.

Data Validation

We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.

Data Triangulation

Industry Analysis

Qualitative Data

Quantitative Data (2017-2025)

  • Market Dynamics (Drivers, Restraints, and Challenges)
  • Industry Trend Analysis
  • Market Opportunities
  • Government Policies and Regulations, Patent Analysis, and Reimbursement Policies
  • Porter’s Five Forces and PESTLE Analysis
  • Key Developments and Competitive Landscape
  • Market Assessment and Forecast
  • Market Assessment and Forecast, By Product
  • Market Assessment and Forecast, By Technology
  • Market Assessment and Forecast, By Application
  • Market Assessment and Forecast, By End User
  • Market Assessment and Forecast, By Region/Country

License Type

For Any Further Assistance